After anti–PD–1 therapy for metastatic malignancies, 10 patients developed painless thyroiditis, 6 patients developed temporary thyrotoxicosis, while four patients showed anti–thyroid antibodies in the serum. The gene discussed is PDCD1; the disease is thyrotoxicosis.